Dobrzanski, M. J., Rewers-Felkins, K. A., Quinlin, I. S., Samad, K. A., Phillips, C. A., Robinson, W., . . . Wright, S. E. (2009). Autologous MUC1-Specific Th1 Effector Cell Immunotherapy Induce Differential Levels of Systemic TReg Cell Subpopulations That Result in Increased Ovarian Cancer Patient Survival.

Dobrzanski, Mark J., Kathleen A. Rewers-Felkins, Imelda S. Quinlin, Khaliquzzaman A. Samad, Catherine A. Phillips, William Robinson, David J. Dobrzanski, und Stephen E. Wright. Autologous MUC1-Specific Th1 Effector Cell Immunotherapy Induce Differential Levels of Systemic TReg Cell Subpopulations That Result in Increased Ovarian Cancer Patient Survival. 2009.

Dobrzanski, Mark J., et al. Autologous MUC1-Specific Th1 Effector Cell Immunotherapy Induce Differential Levels of Systemic TReg Cell Subpopulations That Result in Increased Ovarian Cancer Patient Survival. 2009.